Abstract:Although the mitochondrial permeability transition pore (mPTP) was first discovered almost 30 years ago [1], it did not attract significant research attention until the 1990's when several studies implicated mPTP in apoptosis [2]. Today, the dogma suggests that opening of mPTP is detrimental to the cell and mPTP activation is widely thought to contribute to disease in cancer, neurodegenerative diseases, stroke, muscular dystrophy, and cardiac reperfusion injury [3]. Multiple factors including Ca(2+), OH(-), P(i), cyclophilin D, reactive oxygen and nitrogen species (ROS and RNS) trigger mPTP opening [4]. However, whether mPTP activation feeds back to alter mitochondrial ROS generation remains unclear. We recently demonstrated that under normal conditions, individual mitochondria undergo spontaneous transient bursts of quantal superoxide generation, termed "superoxide flashes" [5]. Superoxide flashes are observed in all cell types investigated to date and are triggered by a surprising functional coupling between mPTP activation and electron transport chain (ETC) dependent superoxide production. Additionally, reoxgenation following anoxia leads to uncontrolled superoxide flash genesis in cardiomyocytes. This positive feedback mechanism for mPTP/ETC-dependent ROS generation may drive localized redox signaling in individual mitochondria under physiological conditions, and when left unchecked, contribute to global cellular oxidative stress under pathological conditions in cardiac disease. The mPTP activity-dependent cell life and death determination imposes new challenges and opportunities in the pursuit of therapeutic agents for treating diseases in which oxidative stress has been implicated such as cardiac ischemia-reperfusion injury.

Reactive species mechanisms of cellular hypoxia-reoxygenation injury

Role of Reactive Oxygen Species in Mediating Hepatic Ischemia-Reperfusion Injury and Its Therapeutic Applications in Liver Transplantation

Molecular Characterization of Reactive Oxygen Species in Myocardial Ischemia-Reperfusion Injury

Oxidative Stress and Lung Ischemia-Reperfusion Injury

The Role of Oxygen Free Radicals in Myocardial Ischemia/reperfusion Injury.

Reactive species mediated injury of human lung epithelial cells after hypoxia-reoxygenation

Oxidative Stress And Nitric Oxide In Cerebral Ischemic Reperfusion Injury

Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: The role of oxidative stress and therapeutic approaches

Reoxygenation Modulates the Adverse Effects of Hypoxia on Wound Repair.

Reoxygenation‐specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia‐reperfusion injury

Molecular Mechanisms of Ischemia–Reperfusion Injury in Brain: Pivotal Role of the Mitochondrial Membrane Potential in Reactive Oxygen Species Generation

Cardiac toxicity of singlet oxygen: implication in reperfusion injury

Endothelial Cell Redox Regulation of Ischemic Angiogenesis

Therapeutic Targets for Regulating Oxidative Damage Induced by Ischemia-Reperfusion Injury: A Study from a Pharmacological Perspective

Oxygen, Reactive Oxygen Species and Tissue Damage

Reactive oxygen species in regulation of hypoxia-inducible factor

Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure

Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury.

NADPH Oxidase 1 and Its Derived Reactive Oxygen Species Mediated Tissue Injury and Repair.

The Mechanisms and Strategies to Protect from Hepatic Ischemia-Reperfusion Injury.

Superoxide Flashes: Illuminating New Insights into Cardiac Ischemia/reperfusion Injury.